These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 26489688)
1. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation. Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688 [TBL] [Abstract][Full Text] [Related]
2. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs. Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304 [TBL] [Abstract][Full Text] [Related]
3. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978 [TBL] [Abstract][Full Text] [Related]
4. Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel. Saravanakumar G; Choi KY; Yoon HY; Kim K; Park JH; Kwon IC; Park K Int J Pharm; 2010 Jul; 394(1-2):154-61. PubMed ID: 20438818 [TBL] [Abstract][Full Text] [Related]
5. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Shi L; Tang C; Yin C Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165 [TBL] [Abstract][Full Text] [Related]
6. A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation. Wang F; Yang S; Hua D; Yuan J; Huang C; Gao Q J Biomater Sci Polym Ed; 2016; 27(3):276-89. PubMed ID: 26578298 [TBL] [Abstract][Full Text] [Related]
7. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497 [TBL] [Abstract][Full Text] [Related]
8. Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel. Li L; Liang N; Wang D; Yan P; Kawashima Y; Cui F; Sun S Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322014 [TBL] [Abstract][Full Text] [Related]
9. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel. Ju C; Sun J; Zi P; Jin X; Zhang C J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931 [TBL] [Abstract][Full Text] [Related]
10. Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro. Tan YL; Liu CG Colloids Surf B Biointerfaces; 2009 Mar; 69(2):178-82. PubMed ID: 19124228 [TBL] [Abstract][Full Text] [Related]
11. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles]. Huo MR; Zhang Y; Zhou JP; Lü L; Liu H; Liu FJ Yao Xue Xue Bao; 2008 Aug; 43(8):855-61. PubMed ID: 18956780 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo. Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997 [TBL] [Abstract][Full Text] [Related]
14. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237 [TBL] [Abstract][Full Text] [Related]
16. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite. Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139 [TBL] [Abstract][Full Text] [Related]
18. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456 [TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes. Yu B; Tang C; Yin C Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Jin X; Mo R; Ding Y; Zheng W; Zhang C Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]